Publication | Open Access

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

Neuro-oncologyCancer ImmunosurveillanceMedicineImmunologyTherapeutic VaccineImmune Checkpoint InhibitorHigh-grade GliomasCare TreatmentImmunotherapyOncologyGlioma